AFT Pharmaceuticals 관리
관리 기준 확인 3/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
Hartley Atkinson
최고 경영자
NZ$974.8k
총 보상
CEO 급여 비율 | 68.7% |
CEO 임기 | 27.2yrs |
CEO 소유권 | 68.7% |
경영진 평균 재임 기간 | 데이터 없음 |
이사회 평균 재임 기간 | 9.4yrs |
최근 관리 업데이트
Recent updates
It's Unlikely That The CEO Of AFT Pharmaceuticals Limited (NZSE:AFT) Will See A Huge Pay Rise This Year
Jul 26AFT Pharmaceuticals Limited (NZSE:AFT) Just Released Its Yearly Results And Analysts Are Updating Their Estimates
May 25Does AFT Pharmaceuticals (NZSE:AFT) Deserve A Spot On Your Watchlist?
May 22Is Now The Time To Put AFT Pharmaceuticals (NZSE:AFT) On Your Watchlist?
Oct 17Should You Be Adding AFT Pharmaceuticals (NZSE:AFT) To Your Watchlist Today?
May 23Is AFT Pharmaceuticals Limited (NZSE:AFT) Trading At A 50% Discount?
Dec 01We Discuss Whether AFT Pharmaceuticals Limited's (NZSE:AFT) CEO Is Due For A Pay Rise
Jul 30With AFT Pharmaceuticals Limited (NZSE:AFT) It Looks Like You'll Get What You Pay For
Jun 02Should You Be Impressed By AFT Pharmaceuticals Limited's (NZSE:AFT) ROE?
Mar 20A Quick Analysis On AFT Pharmaceuticals' (NZSE:AFT) CEO Compensation
Feb 13Are AFT Pharmaceuticals's (NZSE:AFT) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Jan 23Does AFT Pharmaceuticals (NZSE:AFT) Have A Healthy Balance Sheet?
Jan 02Should AFT Pharmaceuticals (NZSE:AFT) Be Disappointed With Their 89% Profit?
Dec 12AFT Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Nov 21CEO 보상 분석
날짜 | 총 보상 | 급여 | 회사 수익 |
---|---|---|---|
Mar 31 2024 | NZ$975k | NZ$670k | NZ$16m |
Dec 31 2023 | n/a | n/a | NZ$13m |
Sep 30 2023 | n/a | n/a | NZ$11m |
Jun 30 2023 | n/a | n/a | NZ$11m |
Mar 31 2023 | NZ$931k | NZ$606k | NZ$11m |
Dec 31 2022 | n/a | n/a | NZ$14m |
Sep 30 2022 | n/a | n/a | NZ$17m |
Jun 30 2022 | n/a | n/a | NZ$18m |
Mar 31 2022 | NZ$840k | NZ$578k | NZ$20m |
Dec 31 2021 | n/a | n/a | NZ$15m |
Sep 30 2021 | n/a | n/a | NZ$11m |
Jun 30 2021 | n/a | n/a | NZ$9m |
Mar 31 2021 | NZ$701k | NZ$506k | NZ$8m |
Dec 31 2020 | n/a | n/a | NZ$5m |
Sep 30 2020 | n/a | n/a | NZ$3m |
Jun 30 2020 | n/a | n/a | NZ$7m |
Mar 31 2020 | NZ$592k | NZ$443k | NZ$12m |
Dec 31 2019 | n/a | n/a | NZ$11m |
Sep 30 2019 | n/a | n/a | NZ$11m |
Jun 30 2019 | n/a | n/a | NZ$4m |
Mar 31 2019 | NZ$556k | NZ$431k | -NZ$3m |
Dec 31 2018 | n/a | n/a | -NZ$7m |
Sep 30 2018 | n/a | n/a | -NZ$11m |
Jun 30 2018 | n/a | n/a | -NZ$12m |
Mar 31 2018 | NZ$514k | NZ$429k | -NZ$14m |
보상 대 시장: Hartley 의 총 보상 ($USD 585.67K )은 NZ 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 617.18K ).
보상과 수익: Hartley 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Hartley Atkinson
27.2yrs
테뉴어
NZ$974,785
보상
Dr. Hartley Atkinson, M.Pharm (Dist), PhD, is Co-Founder of AFT Pharmaceuticals Limited in 1997. Dr. Atkinson is Chief Executive Officer of AFT Pharmaceuticals Limited since September 04, 1997 and also ser...
이사회 구성원
이름 | 위치 | 테뉴어 | 보상 | 소유권 |
---|---|---|---|---|
Co-Founder | 27.2yrs | NZ$974.79k | 68.69% NZ$ 193.0m | |
Co-Founder | 12.2yrs | NZ$175.44k | 데이터 없음 | |
Independent Non-Executive Director | 3.9yrs | NZ$161.04k | 데이터 없음 | |
Independent Chairman | 9.4yrs | NZ$154.00k | 0.17% NZ$ 479.1k | |
Independent Non-Executive Director | 1.2yrs | NZ$50.38k | 데이터 없음 |
9.4yrs
평균 재임 기간
경험이 풍부한 이사회: AFT 의 이사회는 경험(평균 재직 기간 9.4 년)으로 간주됩니다.